Biomedical Engineering Reference
In-Depth Information
16. Nanni CA, Alster TS. Complications of CO
2
laser resurfacing. An eval-
uation of 500 patients. Dermatol Surg 1998; 24: 315.
17. Nanni CA, Alster TS. Complications of cutaneous laser surgery: a
review. Dermatol Surg 1998; 24: 209.
18. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a
high-energy, pulsed CO
2
laser. Dermatol Surg 1996; 22: 151.
19. Adrian RM. Pulsed CO
2
and erbium-YAG laser resurfacing: a compar-
ative clinical and histologic study. J Cutan Laser Ther 1999; 1: 29.
20. Khatri KA, Ross V, Grevelink J, Magro C, Anderson RR. Comparison of
Er:YAG and CO
2
lasers in resurfacing of facial rhytides. Arch Dermatol
1999; 135: 391.
21. Adrian RM. Pulsed CO
2
and long-pulsed 10-ms erbium-YAG laser
resurfacing: a comparative clinical and histologic study. J Cutan Laser
Ther 1999; 1: 197.
22. Khatri KA, Ross V, Grevelink JM, Magro CM, Anderson RR. Compari-
son of erbium:YAG and CO
2
lasers in resurfacing of facial rhytides.
Arch Dermatol 1999; 135: 391.
23. Kaufmann R, Hibst R. Pulsed 2.94 mm Er:YAG laser skin ablation:
experimental results and fi rst clinical application. Clin Exp Dermatol
1990; 15: 389.
24. Kaufmann R, Hibst R. Pulsed Er:YAG and 308 nm UVexcimer laser: an
in vitro and in vivo study of skin ablative effects. Lasers Surg Med 1989;
9: 132.
25. Fitzpatrick RE, Rostan EF, Marchell N. Collagen tightening induced by
CO
2
laser versus Er:YAG laser. Lasers Surg Med 2000; 27: 395.
26. Rostan EF, Fitzpatrick RE, Goldman MP. Laser resurfacing with a long
pulse Er:YAG laser compared to the 950 ms pulsed CO
2
laser. Lasers
Surg Med 2001; 29: 136.
27. Newman JB, Lord JL, Ash K, McDaniel DH. Variable pulse Er:YAG
laser skin resurfacing of perioral rhytides and side-by-side comparison
with CO
2
laser. Lasers Surg Med 2000; 26: 208.
28. Tanzi EL, Alster TS. Treatment of atrophic facial acne scars with a dual-
mode Er : YAG laser. Dermatol Surg 2002; 28: 551.
29. Kwon SD, Kye YC. Treatment of scars with a pulsed Er:YAG laser.
J Cutan Laser Ther 2000; 2: 27.
30. Weinstein C, Schefl an M. Simultaneously combined Er:YAG and
CO
2
laser (Derma K) for skin resurfacing. Clin Plast Surg 2000;
27: 273.
31. Goldman MP, Manuskiatti W. Combined laser resurfacing with the 950
msec pulsed CO
2
+ Er:YAG lasers. Dermatol Surg 1999; 25: 160.
32. McDaniel DH, Lord J, Ash K, Newman J. Combined CO
2
/Erbium:YAG
laser resurfacing of peri-oral rhytides and side-by-side comparison
with CO
2
laser alone. Dermatol Surg 1999; 25: 285-93.
33. Manuskiatti W, Fitzpatrick RE, Goldman MP. Treatment of facial skin
using combinations of CO
2
, Q-switched alexandrite, fl ashlamp-pumped
pulsed dye and Er:YAG lasers in the same treatment session. Dermatol
Surg 2000; 26: 114-20.
34. Spira M, Gerow FJ, Hardy SB. Complications of chemical face peeling.
Plast Reconstr Surg 1974; 54: 397.
35. Litton C. Chemical face lifting. Plast Reconstr Surg 1962; 29: 371.
36. Baker TL, Gordon HL. Chemical face peeling: an adjunct to surgical
facelifting. South Med J 1963; 56: 412.
37. Koch BB, Perkins SW. Simultaneous rhytidectomy and full-face CO
2
laser resurfacing: a case series and meta-analysis. Arch Facial Plast Surg
2002; 4: 227.
38. Weinstein C, Poszner J, Schefl an M. Combined Er:YAG laser resurfac-
ing and face lifting. Plast Reconstr Surg 2001; 107: 586.
39. Roberts TL III, Pozner JN. Lasers, facelifting and the future. Clin Plast
Surg 2000; 2: 293.
40. Kilmer SL, Chotzen VA, Silva SK, McClaren ML. Safe and effective car-
bon dioxide laser skin resurfacing of the neck. Lasers Surg Med 2006;
38: 653-7.
41. Kilmer SL, Chotzen V, Zelickson BD, et al. Full-face laser resurfacing
using a supplemented topical anesthesia protocol. Arch Dermatol
2003; 139: 1279-83.
42. Weinstein C, Ramirez OM, Pozner JN. Postoperative care following CO
2
laser resurfacing: avoiding pitfalls. Plast Reconstr Surg 1997; 100: 1855.
43. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, et al. Infections
complicating CO
2
laser resurfacing. Dermatol Surg 1997; 23: 527.
44. Monheit GD. Facial resurfacing may trigger the herpes simplex virus.
Cosmet Dermatol 1995; 8: 9.
45. Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejci-Papa N. Propylac-
tic antibiotics in patients undergoing laser resurfacing of the skin.
J Am Acad Dermatol 1999; 40: 77.
46. Ross VE, Amesbury EC, Barile A, et al. Incidence of postoperative
infection or positive culture after facial laser resurfacing: a pilot study,
a case report, and a proposal for a rational approach to antibiotic pro-
phylaxis. J Am Acad Dermatol 1998; 39: 975.
47. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus
reactivation after laser skin resurfacing. Dermatol Surg 1999; 25: 242.
48. Batra RS, Ort RJ, Jacob C, et al. Evaluation of a silicone occlusive dress-
ing after laser skin resurfacing. Arch Dermatol 2001; 137: 1317.
49. Goldman MP, Roberts TL III, Skover G, et al. Optimizing wound
healing in the face after laser ablation. J Am Acad Dermatol 2002;
46: 399.
50. Newman JP, Fitzgerald P, Koch RJ. Review of closed dressings after
laser resurfacing. Dermatol Surg 2000; 26: 562.
51. Newman JP, Koch RJ, Goode RL. Closed dressings after laser skin
resurfacing. Arch Otolaryngol Head Neck Surg 1998; 124: 751.
52. Eaglstein WH. Occlusive dressings. J Dermatol Surg Oncol 1993;
19: 716.
53. Horton S, Alster TS. Preoperative and postoperative considerations for
CO
2
laser resurfacing. Cutis 1999; 64: 399.
54. West TB, Alster TS. Effect of pretreatment on the incidence of hyper-
pigmentation following cutaneous CO
2
laser resurfacing. Dermatol
Surg 1999; 25: 15.
55. Grimes PE, Bhawan J, Kim J, et al. Laser resurfacing-induced hypopig-
mentation: histologic alterations and repigmentation with topical
photochemotherapy. Dermatol Surg 2001; 27: 515.
56. Friedman PM, Geronemus RG. Use of the 308-nm laser for postresur-
facing leukoderma. Arch Dermatol 2001; 137: 824.
57. Batra RS, Jacob C, Hobbs L, et al. A prospective survey of patient expe-
riences after laser skin resurfacing. Results from 2.5 years of follow up.
Arch Dermatol 2003; 139: 1295.
58. Ross EV, Swann M, Soon S, et al. Full-face treatments with the 2790-nm
Erbium:YSGG laser system. J Drugs Dermatol 2009; 8: 248-52.
59. DiBernardo B. Assessment of the impact of high-fl uence, high-overlap
settings on full face treatments with the 2,790 nm Pearl YSGG laser.
Laser Surg Med 2008; 40: 91.
60. Munavalli GS, Turley A, Silapunt S, Biesman B. Combining confl uent
and fractionally ablative modalities of a novel 2790 nm YSGG laser for
facial resurfacing. Lasers Surg Med 2011; 43: 273-82.
61. Campo-Voegeli A, Arboles MP. Multi-wavelength single treatment
rejuvenation program. Laser Surg Med 2009; 41: 599.
62. Perez M, Lupo M. Improvement after minimally ablative resurfacing
with the confl uent 2,790 nm YSGG laser: A survey of 44 fee-for-
service patients and their treating physicians. Laser Surg Med 2009;
41: 603.
63. Manstein D, Herron GS, Kink RK, et al. Fractional photothermolysis: a
new concept for cutaneous remodeling using microscopic patterns of
thermal injury. Lasers Surg Med 2004; 34: 426.
64. Dover JS, Smoller BR, Stern RS, et al. Low-fl uence CO
2
laser irradiation
of lentigines. Arch Dermatol 1988; 124: 1219.
65. Kamat BR, Tang SV, Arndt KA, et al. Low-fl uence CO
2
laser irradiation:
selected epidermal damage to human skin. J Invest Dermatol 1985;
85: 274.
66. Wheeland RG. Revision of full-thickness skin grafts using the CO
2
laser. J Dermatol Surg Oncol 1988; 14: 130.
67. Garrett AB, Dufresne RG, Ratz JL, Berlin AJ. CO
2
laser treatment of
pitted acne scarring. J Dermatol Surg Oncol 1990; 16: 737.
68. Goldman L, Shumrick DA, Rockwell J. The laser in maxillofacial sur-
gery: preliminary investigative surgery. Arch Surg 1968; 96: 397.
69. David LM. Laser vermilion ablation for actinic cheilitis. J Dermatol
Surg Oncol 1985; 11: 605.
70. Brauner G, Schliftman A. Laser surgery in children. J Dermatol Surg
Oncol 1987; 13: 178.
71. David LM, Lask GP, Glassberg E, et al. Laser ablation for cosmetic and
medical treatment of facial actinic damage. Cutis 1989; 43: 583.
72. Walsh JJ, Deutsch TF. Pulsed CO
2
laser tissue ablation: measurement of
the ablation rate. Lasers Surg Med 1988; 8: 264.
73. Fitzpatrick RE, Goldman MP, Ruiz-Esparza JR. Clinical advantage of
the CO
2
laser superpulsed mode: treatment of verruca vulgaris, sebor-
